colorectal adenocarcinoma growing from within or invading the lumen of bile ducts, is not a well recognized pattern of tumor growth. Clinical, radiographic, operative, and histopathologic aspects of 15 patients with intrabiliary colorectal metastases were described. Fourteen patients were explored for possible hepatic resection. Two had jaundice, two radiographic evidence of an intrabiliary filling defect, 10 intraoperative evidence of intrabiliary tumor, and six microscopic evidence of intrabiliary tumor. Eleven patients underwent hepatic resection. Five of the resected patients developed hepatic recurrence. Four patients were explored for possible repeat resection. One had jaundice, one radiographic evidence of an intrabiliary filling defect, all had intraoperative evidence of intrabiliary tumor, and three microscopic evidence of intrabiliary tumor. Three patients underwent repeat hepatic resection. All patients with preoperative jaundice and radiographic evidence of an intrabiliary filling defect were unresectable. Overall, actuarial five-year survival is 33% for those patients resected versus 0% for those not resected. Intraoperative recognition of intrabiliary tumor at exploration for hepatic resection was more common than clinical, radiographic, or histopathologic recognition. More diligent exam-
INTRODUCTION
There are approximately 131,000 new cases of colorectal cancer per year in the United States [1] . Approximately 50% of these patients will develop recurrence within five years of treatment of the primary colorectal cancer, with the liver representing the site of recurrence in 40% to 80% of cases [2] [3] [4] [5] . The vast majority of hepatic colorectal metastases represent parenchymal lesions. Diffuse parenchymal disease, which is usually a late finding in patients with extensive tumor involvement of the liver, is the usual cause of jaundice [6] . Much [7, [13] [14] [15] [16] 
